In partnership with the Fraunhofer Center for Molecular Biotechnology and the Walter Reid Army Institute for Research, the Sabin Vaccine Institute has successfully expressed the hookworm-derived antigen Na-APR-1.

A new study asserts that a particular type of schistosomiasis may predispose women to contracting HIV.

The Sabin Sustainable Immunization Financing (SIF) Program was on the agenda at a symposium hosted by the Penn Center for Vaccine Ethics and Policy.

Pages